Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT00828269
Eligibility Criteria:
Inclusion Criteria:
* Patient has chronic hepatitis C (Genotype 1)
* Patient has the ability to avoid use of anticoagulants, nonsteroidal anti-inflammatory drugs and aspirin for at least 5 days before the liver biopsy
Exclusion Criteria:
* Patient has received any approved or investigational drugs for the treatment of hepatitis C in the six months before the liver biopsy
* Patient has HIV or Hepatitis B virus
* Patient has been diagnosed with liver cancer
* Patient has evidence of cirrhosis on any previous liver biopsy
* Patient has confirmed alcohol abuse in the last 12 months
* Patient has participated in any investigational drug study within 90 days before the current study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00828269
Study Brief:
Protocol Section:
NCT00828269